Compare DVAX & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVAX | POWW |
|---|---|---|
| Founded | 1996 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 209.6M |
| IPO Year | 2004 | N/A |
| Metric | DVAX | POWW |
|---|---|---|
| Price | $10.90 | $2.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $26.50 | $2.38 |
| AVG Volume (30 Days) | ★ 1.5M | 367.5K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $330,514,000.00 | $46,632,638.00 |
| Revenue This Year | $24.63 | $9.85 |
| Revenue Next Year | $15.85 | $1.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 26.73 | ★ 1343.57 |
| 52 Week Low | $9.20 | $0.95 |
| 52 Week High | $14.63 | $2.14 |
| Indicator | DVAX | POWW |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 65.73 |
| Support Level | $10.76 | $1.79 |
| Resistance Level | $10.97 | $1.96 |
| Average True Range (ATR) | 0.24 | 0.07 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 22.35 | 86.36 |
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.